The stock of the medical device maker has been stagnant for months and its charts have yet to prove themselves.
Here's how to play ALGN, which is expected to report later Wednesday, three weeks from its Feb. 21 expiration.
The stock of the maker of patient monitoring equipment has been in an uptrend the past year and its charts indicate it could rise even more.
While both companies appear like winners, WBA should have more to gain because of its discounted price.
Let's instead do the kind of security analysis you have to do if you are going to navigate this moment.
3M fell on hard times but could be set to rebound soon.
The NYSE used to be the center of capitalism, but now it's where actual engineering, not financial engineering, is taking place.
Here's how two big events early this week make me view this name that's one of my favorite undervalued, dividend-paying companies.
It's likely the deal goes through, but I don't believe that attempting to take advantage of FIT's current 11% discount is worth the risk.
Our latest analysis on the fitness chain.